17% Salicylate Versus 17% Salicylate-Ethyl Pyruvate for Plantar Foot Warts

Status unconfirmed · Phase 4

Conditions studied: Warts

In brief

Plantar warts on the sole of the foot are among the most common warts seen in podiatry clinics. Some patients are readily cured by simple standard of care treatments that include wart debridement (trimming or excision) and application of 17% salicylate (commercially known as Compound W)or by other treatments that may be painful and affect mobility. No treatment is consistently effective and most patients fail treatment multiple times. Ethyl pyruvate (EP)is a common food additive noted to be 'generally regarded as safe' that may improve the activity of salicylate in wart treatment by improving the ability to penetrate and/or persist in the skin. The use of 17% salicylate with the addition of EP may improve cures of common foot plantar warts in subjects who also be receiving other standard-of-care treatment.

Key facts

Study ID

NCT01712295

Run by

Grossman, Michael, D.P.M.

People needed

100

Starts

2011-11-01

Expected to finish

2014-03-01

Last updated by the study team

2012-10-23

Who can join

Age: 12 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• evidence of skin plantar wart(s)

You may not qualify if…

• iodine allergy

Where it is running

• Main Line Foot and Ankle Center — Ardmore, Pennsylvania, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.